{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:49:59Z","timestamp":1768294199240,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12033-023-00893-x","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T07:01:52Z","timestamp":1699340512000},"page":"2830-2840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients"],"prefix":"10.1007","volume":"66","author":[{"given":"Atefeh","family":"Mohammadloo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazdan","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aghil","family":"Esmaeili-Bandboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Mazloomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Fatemeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Rouhollah","family":"Miri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Hamzelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1287-7877","authenticated-orcid":false,"given":"Ziba","family":"Veisi-Malekshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"issue":"1","key":"893_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neo.2021.11.013","volume":"24","author":"Z Li","year":"2022","unstructured":"Li, Z., Fang, Y., Chen, H., Zhang, T., Yin, X., Man, J., Yang, X., & Lu, M. (2022). Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study. Neoplasia, 24(1), 12\u201321. https:\/\/doi.org\/10.1016\/j.neo.2021.11.013","journal-title":"Neoplasia"},{"issue":"21","key":"893_CR2","doi-asserted-by":"publisher","first-page":"10636","DOI":"10.18632\/oncotarget.2527","volume":"5","author":"R Prasad","year":"2014","unstructured":"Prasad, R., & Katiyar, S. K. (2014). Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21\/WAF1\/Cip1 protein. Oncotarget, 5(21), 10636\u201310649. https:\/\/doi.org\/10.18632\/oncotarget.2527","journal-title":"Oncotarget"},{"key":"893_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038659","author":"X Liu","year":"2012","unstructured":"Liu, X., Fang, H., Chen, H., Jiang, X., Fang, D., Wang, Y., & Zhu, D. (2012). An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0038659","journal-title":"PLoS ONE"},{"key":"893_CR4","doi-asserted-by":"publisher","first-page":"9989824","DOI":"10.1155\/2021\/9989824","volume":"2021","author":"R Bai","year":"2021","unstructured":"Bai, R., Huang, H., Li, M., & Chu, M. (2021). Temporal trends in the incidence and mortality of skin malignant melanoma in China from 1990 to 2019. Journal of Oncology, 2021, 9989824. https:\/\/doi.org\/10.1155\/2021\/9989824","journal-title":"Journal of Oncology"},{"issue":"8","key":"893_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/diagnostics10080577","volume":"10","author":"S Banerjee","year":"2020","unstructured":"Banerjee, S., Singh, S. K., Chakraborty, A., Das, A., & Bag, R. (2020). Melanoma diagnosis using deep learning and fuzzy logic. Diagnostics, 10(8), 577. https:\/\/doi.org\/10.3390\/diagnostics10080577","journal-title":"Diagnostics"},{"issue":"1","key":"893_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5114\/pdia.2013.33376","volume":"30","author":"M Cichorek","year":"2013","unstructured":"Cichorek, M., Wachulska, M., Stasiewicz, A., & Tymi\u0144ska, A. (2013). Skin melanocytes: Biology and development. Postepy Dermatologii i Alergologii, 30(1), 30\u201341. https:\/\/doi.org\/10.5114\/pdia.2013.33376","journal-title":"Postepy Dermatologii i Alergologii"},{"issue":"3","key":"893_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/ijms21030878","volume":"21","author":"F Varrone","year":"2020","unstructured":"Varrone, F., & Caputo, E. (2020). The miRNAs role in melanoma and in its resistance to therapy. International Journal of Molecular Sciences, 21(3), 878. https:\/\/doi.org\/10.3390\/ijms21030878","journal-title":"International Journal of Molecular Sciences"},{"issue":"Suppl 6","key":"893_CR8","doi-asserted-by":"publisher","first-page":"vi8","DOI":"10.1093\/annonc\/mdp251","volume":"20 Suppl 6","author":"H Gogas","year":"2009","unstructured":"Gogas, H., Eggermont, A. M. M., Hauschild, A., Hersey, P., Mohr, P., Schadendorf, D., Spatz, A., & Dummer, R. (2009). Biomarkers in melanoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 20 Suppl 6(Suppl 6), vi8\u2013vi13. https:\/\/doi.org\/10.1093\/annonc\/mdp251","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"2","key":"893_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/biom8020021","volume":"8","author":"SL Mumford","year":"2018","unstructured":"Mumford, S. L., Towler, B. P., Pashler, A. L., Gilleard, O., Martin, Y., & Newbury, S. F. (2018). Circulating microRNA biomarkers in melanoma: Tools and challenges in personalised medicine. Biomolecules, 8(2), 21. https:\/\/doi.org\/10.3390\/biom8020021","journal-title":"Biomolecules"},{"issue":"1","key":"893_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/14737159.2020.1696194","volume":"20","author":"S Carpi","year":"2020","unstructured":"Carpi, S., Polini, B., Fogli, S., Podest\u00e0, A., Yl\u00f6sm\u00e4ki, E., Cerullo, V., Romanini, A., & Nieri, P. (2020). Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma. Expert Review of Molecular Diagnostics, 20(1), 19\u201330. https:\/\/doi.org\/10.1080\/14737159.2020.1696194","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"893_CR11","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7831","author":"T Lu","year":"2019","unstructured":"Lu, T., Chen, S., Qu, L., Wang, Y., Chen, H. D., & He, C. (2019). Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients. PeerJ. https:\/\/doi.org\/10.7717\/peerj.7831","journal-title":"PeerJ"},{"issue":"10","key":"893_CR12","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.26355\/eurrev_201905_17932","volume":"23","author":"J Wang","year":"2019","unstructured":"Wang, J., Fang, Y., Liu, Y. F., Wang, X., Wang, X. L., Wang, R. Y., & Meng, Z. D. (2019). MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator. European Review for Medical and Pharmacological Sciences, 23(10), 4275\u20134284. https:\/\/doi.org\/10.26355\/eurrev_201905_17932","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"893_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1479-5876-10-155","volume":"10","author":"EB Friedman","year":"2012","unstructured":"Friedman, E. B., Shang, S., de Miera, E. V., Fog, J. U., Teilum, M. W., Ma, M. W., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Hernando, E., Baker, A., & Osman, I. (2012). Serum microRNAs as biomarkers for recurrence in melanoma. Journal of Translational Medicine, 10(1), 155. https:\/\/doi.org\/10.1186\/1479-5876-10-155","journal-title":"Journal of Translational Medicine"},{"key":"893_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fcell.2020.00071","volume":"8","author":"M Neagu","year":"2020","unstructured":"Neagu, M., Constantin, C., Cretoiu, S. M., & Zurac, S. (2020). miRNAs in the diagnosis and prognosis of skin cancer. Frontiers in Cell and Developmental Biology, 8, 71. https:\/\/doi.org\/10.3389\/fcell.2020.00071","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"893_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.642380","author":"DC Deacon","year":"2021","unstructured":"Deacon, D. C., Smith, E. A., & Judson-Torres, R. L. (2021). Molecular biomarkers for melanoma screening, diagnosis and prognosis: Current state and future prospects. Frontiers in Medicine. https:\/\/doi.org\/10.3389\/fmed.2021.642380","journal-title":"Frontiers in Medicine"},{"key":"893_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081122","author":"IN Dahmke","year":"2013","unstructured":"Dahmke, I. N., Backes, C., Rudzitis-Auth, J., Laschke, M. W., Leidinger, P., Menger, M. D., Meese, E., & Mahlknecht, U. (2013). Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0081122","journal-title":"PLoS ONE"},{"issue":"20","key":"893_CR17","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak,  K. J., & Guegler, K. J. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 33(20), e179\u2013e179. https:\/\/doi.org\/10.1093\/nar\/gni178","journal-title":"Nucleic Acids Research"},{"key":"893_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2020.100800","volume":"26","author":"M Ghorbani","year":"2020","unstructured":"Ghorbani, M., Pourjafar, F., Saffari, M., & Asgari, Y. (2020). Paclitaxel resistance resulted in a stem-like state in triple-negative breast cancer: A systems biology approach. Meta Gene, 26, 100800. https:\/\/doi.org\/10.1016\/j.mgene.2020.100800","journal-title":"Meta Gene"},{"issue":"3","key":"893_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3892\/or.2017.6173","volume":"39","author":"Y Akiyama","year":"2018","unstructured":"Akiyama, Y., Kiyohara, Y., Yoshikawa, S., Otsuka, M., Kondou, R., Nonomura, C., Miyata, H., Iizuka, A., Ashizawa, T., Ohshima, K., Urakami, K., Nagashima, T.,  Kusuhara, M., Sugino, T., & Yamaguchi, K. (2018). Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis. Oncology Reports, 39(3), 1125\u20131131. https:\/\/doi.org\/10.3892\/or.2017.6173","journal-title":"Oncology Reports"},{"issue":"4","key":"893_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.30699\/ijp.2019.85213.1801","volume":"14","author":"P Salehi","year":"2019","unstructured":"Salehi, P., Tafvizi, F., & Kamyab Hesari, K. (2019). Low expression of occludin in the melanoma patient. Iranian Journal of Pathology, 14(4), 272\u2013278. https:\/\/doi.org\/10.30699\/ijp.2019.85213.1801","journal-title":"Iranian Journal of Pathology"},{"issue":"12","key":"893_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115293","volume":"9","author":"LH Yang","year":"2015","unstructured":"Yang, L. H., Wang, S. L., Tang, L. L., Liu, B., Ye, W. L., Wang, L. L., Wang, Z. Y., Zhou, M. T., & Chen, B. C. (2015). Universal stem-loop primer method for screening and quantification of microRNA. PLoS ONE, 9(12), e115293. https:\/\/doi.org\/10.1371\/journal.pone.0115293","journal-title":"PLoS ONE"},{"key":"893_CR22","doi-asserted-by":"crossref","unstructured":"Shi, R., Sun, Y. -H., Zhang,  X. -H., & Chiang, V. L. (2012).  Poly(T) adaptor RT-PCR. In: Fan, JB. (eds), Next-generation microRNA expression profiling technology. Methods in Molecular Biology (pp. 53\u201366). Humana Press, Totowa, NJ","DOI":"10.1007\/978-1-61779-427-8_4"},{"issue":"2","key":"893_CR23","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1532\/hsf.1887","volume":"21","author":"A Esmaeili-bandboni","year":"2018","unstructured":"Esmaeili-bandboni, A., Bagheri, J., Bakhshandeh, A. R., Mohammadnejad, J., & Sadroddiny, E. (2018). Serum levels of miR-155, miR-326, and miR-133b as early diagnostic biomarkers for the detection of human acute heart allograft rejection in comparison with serum cardiac troponin T. The Heart Surgery Forum, 21(2), E101\u2013E107. https:\/\/doi.org\/10.1532\/hsf.1887","journal-title":"The Heart Surgery Forum"},{"issue":"1","key":"893_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-15-29","volume":"15","author":"PK Busk","year":"2014","unstructured":"Busk, P. K. (2014). A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics, 15(1), 1\u20139. https:\/\/doi.org\/10.1186\/1471-2105-15-29","journal-title":"BMC Bioinformatics"},{"key":"893_CR25","doi-asserted-by":"crossref","unstructured":"Barartabar, Z., Moini, N., Abbasalipourkabir, R., Mesbah-Namin, S. A., & Ziamajidi, N. (2022). Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K\/AKT signaling in women with breast cancer.","DOI":"10.21203\/rs.3.rs-2204784\/v1"},{"key":"893_CR26","doi-asserted-by":"publisher","first-page":"5298006","DOI":"10.1155\/2021\/5298006","volume":"2021","author":"A Bahramy","year":"2021","unstructured":"Bahramy, A., Zafari, N., Izadi, P., Soleymani, F., Kavousi, S., & Noruzinia, M. (2021). The role of miRNAs 340-5p, 92a-3p, and 381-3p in patients with endometriosis: A plasma and mesenchymal stem-like cell study. BioMed Research International, 2021, 5298006. https:\/\/doi.org\/10.1155\/2021\/5298006","journal-title":"BioMed Research International"},{"issue":"3","key":"893_CR27","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao, X., Huang, X., Zhou, Z., & Lin, X. (2013). An improvement of the 2^(\u2212\u00a0delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, Bioinformatics and Biomathematics, 3(3), 71\u201385.","journal-title":"Biostatistics, Bioinformatics and Biomathematics"},{"key":"893_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","volume":"63","author":"C Garbe","year":"2016","unstructured":"Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Bastholt, L., Grob, J. J., Malvehy, J., Newton-Bishop, J., Stratigos, A. J., & Pehamberger, H. (2016). Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline\u2014Update 2016. European Journal of Cancer, 63, 201\u2013217. https:\/\/doi.org\/10.1016\/j.ejca.2016.05.005","journal-title":"European Journal of Cancer"},{"issue":"65","key":"893_CR29","doi-asserted-by":"publisher","first-page":"32507","DOI":"10.18632\/oncotarget.25986","volume":"9","author":"T Korda\u00df","year":"2018","unstructured":"Korda\u00df, T., Weber, C. E. M., Eisel, D., Pane, A. A., Osen, W., & Eichm\u00fcller, S. B. (2018). miR-193b and miR-30c-1(*) inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro. Oncotarget, 9(65), 32507\u201332522. https:\/\/doi.org\/10.18632\/oncotarget.25986","journal-title":"Oncotarget"},{"issue":"8","key":"893_CR30","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1111\/jcmm.15111","volume":"24","author":"Q Wang","year":"2020","unstructured":"Wang, Q., Xu, K., Tong, Y., Dai, X., Xu, T., He, D., & Ying, J. (2020). Novel miRNA markers for the diagnosis and prognosis of endometrial cancer. Journal of Cellular and Molecular Medicine, 24(8), 4533\u20134546. https:\/\/doi.org\/10.1111\/jcmm.15111","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"893_CR31","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.2353\/ajpath.2010.091061","volume":"176","author":"J Chen","year":"2010","unstructured":"Chen, J., Feilotter, H. E., Par\u00e9, G. C., Zhang, X., Pemberton, J. G., Garady, C., Lai, D., Yang, X., & Tron, V. A. (2010). MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. American Journal of Pathology, 176(5), 2520\u20132529. https:\/\/doi.org\/10.2353\/ajpath.2010.091061","journal-title":"American Journal of Pathology"},{"issue":"10","key":"893_CR32","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/onc.2012.141","volume":"32","author":"J Chen","year":"2013","unstructured":"Chen, J., Abi-Daoud, M., Wang, A., Yang, X., Zhang, X., Feilotter, H. E., & Tron, V. A. (2013). Stathmin 1 is a potential novel oncogene in melanoma. Oncogene, 32(10), 1330\u20131337. https:\/\/doi.org\/10.1038\/onc.2012.141","journal-title":"Oncogene"},{"issue":"48","key":"893_CR33","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1038\/onc.2015.43","volume":"34","author":"AK Mitra","year":"2015","unstructured":"Mitra, A. K., Chiang, C. Y., Tiwari, P., Tomar, S., Watters, K. M., Peter, M. E., & Lengyel, E. (2015). Microenvironment-induced down regulation of miR-193b drives ovarian cancer metastasis. Oncogene, 34(48), 5923\u20135932. https:\/\/doi.org\/10.1038\/onc.2015.43","journal-title":"Oncogene"},{"key":"893_CR34","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.12659\/msm.895407","volume":"21","author":"H Li","year":"2015","unstructured":"Li, H., Xu, Y., Qiu, W., Zhao, D., & Zhang, Y. (2015). Tissue miR-193b as a novel biomarker for patients with ovarian cancer. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 21, 3929\u20133934. https:\/\/doi.org\/10.12659\/msm.895407","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"issue":"1","key":"893_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CEJ.0b013e328305a07a","volume":"18","author":"W Wu","year":"2009","unstructured":"Wu, W., Lin, Z., Zhuang, Z., & Liang, X. (2009). Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. European Journal of Cancer Prevention: Official Journal of the European Cancer Prevention Organization, 18(1), 50\u201355. https:\/\/doi.org\/10.1097\/CEJ.0b013e328305a07a","journal-title":"European Journal of Cancer Prevention: Official Journal of the European Cancer Prevention Organization"},{"issue":"6","key":"893_CR36","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/ijc.25162","volume":"127","author":"HE Rauhala","year":"2010","unstructured":"Rauhala, H. E., Jalava, S. E., Isotalo, J., Bracken, H., Lehmusvaara, S., Tammela, T. L., Oja, H., & Visakorpi, T. (2010). miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. International Journal of Cancer, 127(6), 1363\u20131372. https:\/\/doi.org\/10.1002\/ijc.25162","journal-title":"International Journal of Cancer"},{"issue":"10","key":"893_CR37","doi-asserted-by":"publisher","first-page":"16861","DOI":"10.1002\/jcp.28368","volume":"234","author":"M Khordadmehr","year":"2019","unstructured":"Khordadmehr, M., Shahbazi, R., Sadreddini, S., & Baradaran, B. (2019). miR-193: A new weapon against cancer. Journal of Cellular Physiology, 234(10), 16861\u201316872. https:\/\/doi.org\/10.1002\/jcp.28368","journal-title":"Journal of Cellular Physiology"},{"issue":"44","key":"893_CR38","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1038\/onc.2009.241","volume":"28","author":"SK Leivonen","year":"2009","unstructured":"Leivonen, S. K., M\u00e4kel\u00e4, R., \u00d6stling, P., Kohonen, P., Haapa-Paananen, S., Kleivi, K., Enerly, E., Aakula, A., Hellstr\u00f6m, K., Sahlberg, N., & Kristensen, V. N. (2009). Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene, 28(44), 3926\u20133936. https:\/\/doi.org\/10.1038\/onc.2009.241","journal-title":"Oncogene"},{"issue":"1","key":"893_CR39","doi-asserted-by":"publisher","first-page":"13996","DOI":"10.1038\/s41598-017-14454-1","volume":"7","author":"J-A Hulin","year":"2017","unstructured":"Hulin, J.-A., Tommasi, S., Elliot, D., Hu, D. G., Lewis, B. C., & Mangoni, A. A. (2017). MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1. Scientific Reports, 7(1), 13996. https:\/\/doi.org\/10.1038\/s41598-017-14454-1","journal-title":"Scientific Reports"},{"issue":"44","key":"893_CR40","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/onc.2009.245","volume":"28","author":"X-F Li","year":"2009","unstructured":"Li, X.-F., Yan, P.-J., & Shao, Z.-M. (2009). Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene, 28(44), 3937\u20133948. https:\/\/doi.org\/10.1038\/onc.2009.245","journal-title":"Oncogene"},{"issue":"4","key":"893_CR41","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3892\/ol.2017.5763","volume":"13","author":"K Wu","year":"2017","unstructured":"Wu, K., Zhao, Z., Ma, J., Chen, J., Peng, J., Yang, S., & He, Y. (2017). Deregulation of miR-193b affects the growth of colon cancer cells via transforming growth factor-\u03b2 and regulation of the SMAD3 pathway. Oncology Letters, 13(4), 2557\u20132562. https:\/\/doi.org\/10.3892\/ol.2017.5763","journal-title":"Oncology Letters"},{"issue":"5","key":"893_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jnr.23339","volume":"92","author":"Q Zhong","year":"2014","unstructured":"Zhong, Q., Wang, T., Lu, P., Zhang, R., Zou, J., & Yuan, S. (2014). miR-193b promotes cell proliferation by targeting SMAD3 in human glioma. Journal of Neuroscience Research, 92(5), 619\u2013626. https:\/\/doi.org\/10.1002\/jnr.23339","journal-title":"Journal of Neuroscience Research"},{"key":"893_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1476-4598-12-162","volume":"12","author":"A Salvi","year":"2013","unstructured":"Salvi, A., Conde, I., Abeni, E., Arici, B., Grossi, I., Specchia, C., Portolani, N., Barlati, S., & De Petro, G. (2013). Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. Molecular Cancer, 12, 162. https:\/\/doi.org\/10.1186\/1476-4598-12-162","journal-title":"Molecular Cancer"},{"issue":"15","key":"893_CR44","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1016\/j.ejca.2010.06.127","volume":"46","author":"C Xu","year":"2010","unstructured":"Xu, C., Liu, S., Fu, H., Li, S., Tie, Y., Zhu, J., Xing, R., Jin, Y., Sun, Z., & Zheng, X. (2010). MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. European Journal of Cancer, 46(15), 2828\u20132836. https:\/\/doi.org\/10.1016\/j.ejca.2010.06.127","journal-title":"European Journal of Cancer"},{"issue":"10","key":"893_CR45","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1167\/iovs.16-19862","volume":"57","author":"AC Larsen","year":"2016","unstructured":"Larsen, A. C., Mikkelsen, L. H., Borup, R., Kiss, K., Toft, P. B., von Buchwald, C., Coupland, S. E., Prause, J. U., & Heegaard, S. (2016). MicroRNA expression profile in conjunctival melanoma. Investigative Ophthalmology & Visual Science, 57(10), 4205\u20134212. https:\/\/doi.org\/10.1167\/iovs.16-19862","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"893_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/physiolgenomics.00133.2016","volume":"49","author":"MR Paterson","year":"2017","unstructured":"Paterson, M. R., & Kriegel, A. J. (2017). MiR-146a\/b: A family with shared seeds and different roots. Physiological Genomics, 49(4), 243\u2013252. https:\/\/doi.org\/10.1152\/physiolgenomics.00133.2016","journal-title":"Physiological Genomics"},{"issue":"2","key":"893_CR47","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.canlet.2013.06.018","volume":"339","author":"Y Li","year":"2013","unstructured":"Li, Y., Wang, Y., Yu, L., Sun, C., Cheng, D., Yu, S., Wang, Q., Yan, Y., Kang, C., Jin, S., & An, T. (2013). miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. Cancer Letters, 339(2), 260\u2013269. https:\/\/doi.org\/10.1016\/j.canlet.2013.06.018","journal-title":"Cancer Letters"},{"issue":"12","key":"893_CR48","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/thy.2017.0626","volume":"28","author":"C Yu","year":"2018","unstructured":"Yu, C., Zhang, L., Luo, D., Yan, F., Liu, J., Shao, S., Zhao, L., Jin, T., Zhao, J., & Gao, L. (2018). MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer. Thyroid, 28(12), 1627\u20131641. https:\/\/doi.org\/10.1089\/thy.2017.0626","journal-title":"Thyroid"},{"issue":"1","key":"893_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2164-11-52","volume":"11","author":"G Jagadeeswaran","year":"2010","unstructured":"Jagadeeswaran, G., Zheng, Y., Sumathipala, N., Jiang, H., Arrese, E. L., Soulages, J. L., Zhang, W., & Sunkar, R. (2010). Deep sequencing of small RNA libraries reveals dynamic regulation of conserved and novel microRNAs and microRNA-stars during silkworm development. BMC Genomics, 11(1), 52. https:\/\/doi.org\/10.1186\/1471-2164-11-52","journal-title":"BMC Genomics"},{"key":"893_CR50","doi-asserted-by":"publisher","first-page":"8718321","DOI":"10.1155\/2020\/8718321","volume":"2020","author":"Z Su","year":"2020","unstructured":"Su, Z., & Wu, F. (2020). Inflammatory factors induce thrombosis through the miR-146b-3p\/p38MAPK\/COX-2 pathway. BioMed Research International, 2020, 8718321. https:\/\/doi.org\/10.1155\/2020\/8718321","journal-title":"BioMed Research International"},{"issue":"8","key":"893_CR51","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1158\/0008-5472.CAN-09-4456","volume":"70","author":"A Veronese","year":"2010","unstructured":"Veronese, A., Lupini, L., Consiglio, J., Visone, R., Ferracin, M., Fornari, F., Zanesi, N., Alder, H., D\u2019Elia, G., Gramantieri, L., & Bolondi, L. (2010). Oncogenic role of miR-483-3p at the IGF2\/483 locus. Cancer Research, 70(8), 3140\u20133149. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4456","journal-title":"Cancer Research"},{"issue":"1","key":"893_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.febslet.2010.11.039","volume":"585","author":"J Hao","year":"2011","unstructured":"Hao, J., Zhang, S., Zhou, Y., Hu, X., & Shao, C. (2011). MicroRNA 483-3p suppresses the expression of DPC4\/SMAD4 in pancreatic cancer. FEBS Letters, 585(1), 207\u2013213. https:\/\/doi.org\/10.1016\/j.febslet.2010.11.039","journal-title":"FEBS Letters"},{"issue":"1","key":"893_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jcmm.12649","volume":"20","author":"X Yu","year":"2016","unstructured":"Yu, X., & Li, Z. (2016). The role of miRNAs in cutaneous squamous cell carcinoma. Journal of Cellular and Molecular Medicine, 20(1), 3\u20139. https:\/\/doi.org\/10.1111\/jcmm.12649","journal-title":"Journal of Cellular and Molecular Medicine"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00893-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00893-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:07:21Z","timestamp":1728608841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00893-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00893-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical principles and the national norms and standards for conducting medical research in Iran. Approval ID: IR.TUMS.MEDICINE.REC.1400.453, evaluated by Research Ethics Committees of School of Medicine\u2014Tehran University of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors claim that human research subjects gave their informed permission.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}